CD9 and chronic kidney disease: Given the potential importance of RA/RAR signalling in the CD9 and the potential differences in vitro and in vivo, it is desirable to clarify how renal RA/RAR activity is regulated in different types of AKI and CKD in RARE-reporter animals21,22,39,40 and in related clinical settings.